| BioWorld

Are patient-reported outcomes getting lost in translation?

Analysis shows V-Go helps reduce Type 2 diabetes management cost

MDD's Stock Report: Winners and Losers

HIT Bits: Dexcom develops CGM solution for Apple Watch

Grants: United Health Foundation gives TPCA $900,000 funding for telehealth

Direct Flow Medical gains patient expansion approval in SALUS trial

Direct Flow Medical (Santa Rosa, California) said it has received FDA approval to broaden its SALUS trial including the addition of high risk patients and randomization against Medtronic's (Dublin) CoreValve. Read More

Report from Asia: China steps up efforts to regulate IVD reagents market

BioWorld MedTech

April 13, 2015

Are patient-reported outcomes getting lost in translation?

Analysis shows V-Go helps reduce Type 2 diabetes management cost

MDD's Stock Report: Winners and Losers

MDD's Company Stock Report

HIT Bits: Dexcom develops CGM solution for Apple Watch

Grants: United Health Foundation gives TPCA $900,000 funding for telehealth

Briefly Noted

Product briefs

People in Places

MDD's Neurology Extra

Direct Flow Medical gains patient expansion approval in SALUS trial

Report from Asia: China steps up efforts to regulate IVD reagents market

Today's news in brief

Today's news in brief

Biopharma exempt from US reciprocal tariffs, but not untouched

ADPD 2025: Unlocking GLP-1's potential in neurodegeneration

News in brief